Clare Daly
Ceist:413. Deputy Clare Daly asked the Minister for Health his views on the Gardasil HPV vaccine containing thiaminase; and if he will make a statement on the matter. [4216/18]
Amharc ar fhreagraTuesday, 30 January 2018
Ceisteanna (413, 446, 455)
Michael Healy-Rae
Ceist:446. Deputy Michael Healy-Rae asked the Minister for Health if he will address a matter (details supplied) regarding the Gardasil HPV vaccine; and if he will make a statement on the matter. [4417/18]
Amharc ar fhreagra
Michael Moynihan
Ceist:455. Deputy Michael Moynihan asked the Minister for Health if the Gardasil HPV vaccine contains thiaminase, which is an enzyme used in the manufacture of the vaccine; and if studies have been carried out as to whether thiaminase can destroy or inactivate thiamine and cause a vitamin deficiency disease. [4494/18]
Amharc ar fhreagraFreagraí scríofa
I propose to take Questions Nos. 413, 446 and 455 together.
The information that the Deputies seek with regard to Thiaminase is not readily available. Therefore, I have asked the Health Products Regulatory Authority to investigate the matter and reply directly to each Deputy.
However I think it is important to reiterate that the Health Products Regulatory Authority and the European Medicines Agency continually monitor adverse events to vaccination. HPV is one of the most closely studied and monitored medicinal products. The vast majority of reports received by the HPRA have been consistent with the expected pattern of short term adverse side effects for the vaccine, as described in the product information. These are usually mild and temporary reactions to any kind of vaccination.